BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2005
View Archived Issues
Buprenorphine attracts different patients with opioid dependence
Read More
Peginterferon alfa-2a reported more effective than lamivudine in hepatitis B
Read More
Adjuvant oral capecitabine therapy proven effective in colon cancer
Read More
Immunomodulators claimed in recent patents
Read More
New treatments for cancer reported in patent literature
Read More
Senju scientists synthesize novel calpain inhibitors
Read More
Garlic oil and allitridin improve glycemic control in diabetic rats
Read More
Bio-E-Gel reported to reduce hot flashes in menopausal women
Read More
Oblimersen plus rituximab shows efficacy in recurrent B-cell NHL
Read More
INS-316 improves sensitivity of lung cancer diagnosis with sputum specimens
Read More
Phase I data on the pharmacokinetics and safety of EKB-569 in advanced cancer patients
Read More
Pralatrexate shows promise in the treatment of advanced NSCLC
Read More
Prous Science to host Annual European Forum
Read More
Alfresa and AnGes collaborate on agent for atopic dermatitis in Japan
Read More
Lundbeck and PAION partner on desmoteplase
Read More
Enrollment completed in phase III trial of Infergen for HCV
Read More
MLN-1202 enters phase II study for relapsing-remitting MS
Read More
Final cohort begins dosing in phase II study of SABER-Bupivacaine
Read More
Phase IIb study evaluates BXL-628 for benign prostatic hyperplasia
Read More
AstraZeneca and Avanir establish reverse cholesterol transport collaboration
Read More
New River obtains license for technology to reduce opioid tolerance
Read More
VioQuest to acquire Greenwich Therapeutics
Read More
Arexis names fat malabsorption treatment Exinalda
Read More
Antares develops proprietary antianxiety transdermal gel
Read More
Canadian panel recommends return of Vioxx to market
Read More
U.S. antitrust approval for merger of Sankyo and Daiichi
Read More
Prous Science webcasts more than 100 hours of ADA 65th Scientific Session
Read More